a public good project by the
Synthesis
Company
of California

© 2026

Daniel J. Drucker | doi.page

0 works0 citations0 h-index

Daniel J. Drucker

University of Toronto(CA)Lunenfeld-Tanenbaum Research Institute(CA)

Publications by Year

Research Areas

Diabetes Treatment and Management, Pancreatic function and diabetes, Neuropeptides and Animal Physiology, Metabolism, Diabetes, and Cancer, Neuroendocrine Tumor Research Advances

Most-Cited Works

→ The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes(2006)3,845 cited
→ Biology of Incretins: GLP-1 and GIP(2007)3,531 cited
→ The biology of incretin hormones(2006)2,140 cited
→ Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1(2018)1,752 cited
→ Glucagon-like peptide 1 (GLP-1)(2019)1,649 cited
→ Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action(2013)1,426 cited
→

FTO Obesity Variant Circuitry and Adipocyte Browning in Humans

(2015)

1,372 cited

→ Normalization of obesity-associated insulin resistance through immunotherapy(2009)1,336 cited

→ Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study(2008)1,061 cited

→ Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways(2008)1,037 cited